An advisory body on emerging healthcare scientific developments and their ethical, legal, social and economic implications.
The ESBAC members’ terms of office came to an end on 31 May 2014 and ESBAC will not be continuing as a committee
Role of the committee
The Emerging Science and Bioethics Advisory Committee (ESBAC) was the main UK advisory body on emerging healthcare scientific developments and their ethical, legal, social and economic implications.
It was sponsored by the Chief Medical Officer (CMO) for the Department of Health (DH), England. Its membership included representation from all UK Health Departments for whom ESBAC also provided advice. ESBAC also provided a forum to consider and develop coordinated advice across the wider science, health and academic communities to help set priorities in response to new developments.
Membership list (PDF, 99.1KB, 2 pages)
Register of members' interests (PDF, 209KB, 14 pages)
7 February 2014: agenda and minutes (ZIP, 41.3KB)
30 September 2013: agenda and minutes (ZIP, 86.6KB)
13 May 2013: forum agenda, summary and slides (ZIP, 1.41MB)
29 January 2013: agenda, minutes and meeting papers (ZIP, 878KB)
17 July 2012: agenda, minutes and meeting papers (ZIP, 527KB)
Code of practice and terms of reference
Code of practice (including terms of reference) (PDF, 407KB, 25 pages)